Quanex Building Products earnings release, June 4, 2026

Quanex Building Products CORP (NX) · Form 8-K, Item 2.02 · Filed · SEC filing

Quanex Building Products Announces Second Quarter 2026 Results

Net Sales Growth of ~2% Year-Over-Year

Volumes Tracking Normal Seasonality Patterns

Price vs Cost Imbalance Being Addressed

Executing on Working Capital Management

HOUSTON, June 04, 2026 (GLOBE NEWSWIRE) --

Quanex Building Products Corporation

(NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended April 30, 2026.

The Company reported the following selected financial results:

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, “Despite the headwinds our industry is facing, demand for the products we manufacture was as expected during the second quarter of 2026. Rapid inflationary pressures related to macroeconomic concerns and the ongoing conflict in the Middle East led to an unfavorable price versus cost dynamic, which pressured our margins. As previously disclosed, we utilize surcharges to respond to rapid increases in costs and we have index pricing mechanisms in place in North America to handle fluctuations in major raw material costs, but when costs increase quickly there is a timing lag and margins are negatively impacted. We are addressing the current price versus cost imbalance to minimize further negative impact and expect to recover some of the shortfall to date during the second half of this year, assuming volumes continue to track the normal seasonality of our business, and the rate of inflationary pressure subsides.

“We expected to be a net borrower during the second quarter due to the seasonality of our business, coupled with the longer cash conversion cycle of the legacy Tyman business, but continued execution on managing working capital, coupled with the seasonal uptick in volumes, enabled us to avoid being a net borrower for the quarter. We intend to prioritize debt repayment and opportunistic share repurchases as we generate cash in the second half. In addition, we will continue to focus on the things we can control, which includes identifying operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence improves and demand rebounds.”

Second Quarter 2026 Results Summary

Quanex reported net sales of $462.4 million during the three months ended April 30, 2026, which represents an increase of 2.2% compared to $452.5 million for the same period in 2025, mainly due to favorable impacts from pricing, including tariff-related price recoveries, and foreign exchange translation. The Hardware Solutions and Extruded Solutions segments each reported modest increases in net sales for the second quarter of 2026, as lower volumes were offset by favorable impacts from pricing, including tariff-related recoveries and foreign exchange translation. Quanex reported an increase of 6.6% in net sales for the second quarter of 2026 in its Custom Solutions segment, largely due to increased volume and improved pricing. (See Sales Analysis table for additional information)

On a consolidated basis, the decrease in adjusted earnings for the second quarter of 2026 compared to the second quarter of 2025 was mainly due to reduced operating leverage from lower volumes related to ongoing macroeconomic uncertainty combined with weak consumer confidence, tariff-related costs and inflationary pressures. More specifically, due to the ongoing war in the Middle East, the Company realized a significant increase in transportation and raw material costs during the quarter.

Balance Sheet & Liquidity Update

As of April 30, 2026, the Company had total debt of $715.0 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was 3.1x. As of April 30, 2026, Quanex reported a LTM Net Loss of $257.2 million, mainly due to the non-cash goodwill impairment charge recorded in the third quarter of 2025, and LTM Adjusted EBITDA of $212.8 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity was $328.6 million as of April 30, 2026, consisting of $63.7 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Conference Call and Webcast Information

The Company has scheduled a conference call for Friday, June 5, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register-conf.media-server.com/register/BIcb9c8924a43d483f9a1238134ae8964f

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Contact:

Scott Zuehlke

SVP, Chief Financial Officer & Treasurer

713-877-5327 scott.zuehlke@quanex.com

Non-GAAP Terminology Definitions and Disclaimers... (truncatencome (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflect operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. These measures allow management and investors to evaluate operational performance and trends without the impact of certain non-cash charges, acquisition-related costs, and other items that may vary significantly from period to period and may not be reflective of Quanex’s core operating results. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Financial statements

Income Statement

Three Months Ended April 30, — The Company reported the following selected financial results: ($ in millions, except per share data)

Three Months Ended April 30, – 2026Three Months Ended April 30, – 2025Six Months Ended April 30, – 2026Six Months Ended April 30, – 2025
Net Sales462.4452.5871.5852.5
Gross Margin117.8131.4216.3223.7
Gross Margin %25.5%29.0%24.8%26.2%
Net Income (Loss)3.420.5-0.75.6
Diluted EPS0.070.44-0.020.12
Adjusted Net Income11.329.11138.1
Adjusted Diluted EPS0.250.630.240.81
Adjusted EBITDA44.263.171.6101.7
Adjusted EBITDA Margin %9.6%14.0%8.2%11.9%
Cash Provided By (Used For) Operating Activities18.928.5-1.316
Free Cash Flow7.913.6-23.6-10.6

Income Statement (In thousands, except per share data)

Three Months Ended April 30, – 2026Three Months Ended April 30, – 2025Six Months Ended April 30, – 2026Six Months Ended April 30, – 2025
Net sales462,367452,478871,456852,522
Cost of sales344,575321,096655,137628,824
Selling, general and administrative74,43270,333145,858136,983
Restructuring charges9368,840
Depreciation and amortization24,65019,19248,89943,932
Operating income18,71040,92121,56233,943
Interest expense-12,042-13,940-24,409-28,126
Other, net448-1596,0651,070
Income before income taxes7,11626,8223,2186,887
Income tax expense-3,766-6,307-3,939-1,257
Net income (loss)3,35020,515-7215,630
Earnings (loss) per common share, basic0.070.44-0.020.12
Earnings (loss) per common share, diluted0.070.44-0.020.12
Weighted average common shares outstanding:Basic45,48346,48345,46946,753
Weighted average common shares outstanding:Diluted45,65846,56345,46946,868
Weighted average common shares outstanding:Cash dividends per share0.080.080.160.16

Income Statement

(2) Excludes outstanding letters of credit. (In thousands, except per share data)

Three Months Ended April 30, 2026 – ReconciliationThree Months Ended January 31, 2026 – ReconciliationThree Months Ended October 31, 2025 – ReconciliationThree Months Ended July 31, 2025 – ReconciliationTotal – Reconciliation
Net income (loss) as reported3,350-4,07119,571-276,007-257,157
Income tax expense (benefit)3,76617315,147-8,19110,895
Other, net-448-5,617-5,246-855-12,166
Interest expense12,04212,36713,46814,21852,095
Depreciation and amortization24,65024,24925,63033,882108,411
Asset impairment charges302,284302,284
EBITDA43,36027,10168,57065,331204,362
Cost of sales (1)121407308148984
Selling, general and administrative (1),(2)688-1262,0563,4496,067
Restructuring (credit) charges (3)-161,3671,351
Adjusted EBITDA44,16927,38270,91870,295212,764

Income Statement

(3) Restructuring (credit) charges related to severance. (In thousands, except per share data)

Three Months Ended April 30, 2026 – Net IncomeReconciliationIncome StatementThree Months Ended April 30, 2026 – Diluted EPSReconciling ItemsThree Months Ended April 30, 2025 – Net IncomeReconciliationIncome StatementThree Months Ended April 30, 2025 – Diluted EPSReconciling ItemsSix Months Ended April 30, 2026 – Net IncomeReconciliationIncome StatementSix Months Ended April 30, 2026 – Diluted EPSReconciling ItemsSix Months Ended April 30, 2025 – Net IncomeReconciliationIncome StatementSix Months Ended April 30, 2025 – Diluted EPSReconciling Items
Net income (loss) as reported3,3500.0720,5150.44-721-0.025,6300.12
Net income reconciling items from below7,9130.188,5970.1911,7140.2632,4440.69
Adjusted net income and adjusted EPS11,2630.2529,1120.6310,9930.2438,0740.81
Reconciliation of Adjusted EBITDAThree Months Ended April 30, 2026Three Months Ended April 30, 2025Six Months Ended April 30, 2026Six Months Ended April 30, 2025
Net income (loss) as reported3,35020,515-7215,630
Income tax expense3,7666,3073,9391,257
Other, net-448159-6,065-1,070
Interest expense12,04213,94024,40928,126
Depreciation and amortization24,65019,19248,89943,932
EBITDA43,36060,11370,46177,875
EBITDA reconciling items from below8093,0221,09023,802
Adjusted EBITDA44,16963,13571,551101,677
Reconciling ItemsThree Months Ended April 30, 2026Three Months Ended April 30, 2025Six Months Ended April 30, 2026Six Months Ended April 30, 2025
Net sales462,367$-452,478$-871,456$-852,522$-

Income Statement

Hardware Solutions (in thousands)

Three months ended April 30, 2026 – Hardware SolutionsThree months ended April 30, 2026 – Extruded SolutionsThree months ended April 30, 2026 – Custom SolutionsThree months ended April 30, 2026 – Unallocated Corp & OtherThree months ended April 30, 2026 – Total
Net sales203,019164,949103,913-9,514462,367
Cost of sales162,392112,88179,017-9,715344,575
Gross Margin40,62752,06824,896201117,792
Gross Margin %20.0%31.6%24.0%25.5%
Selling, general and administrative (1)35,76321,66413,8893,11674,432
Depreciation and amortization11,6937,3415,40421224,650
Operating (loss) income-6,82923,0635,603-3,12718,710
Depreciation and amortization11,6937,3415,40421224,650
EBITDA4,86430,40411,007-2,91543,360
Expense related to plant relocation (Cost of sales)121121
Expense related to plant relocation (SG&A)134134
Reorganization costs751478554
Adjusted EBITDA5,19430,40411,008-2,43744,169
Adjusted EBITDA Margin %2.6%18.4%10.6%9.6%
Three months ended April 30, 2025Net sales202,935163,96797,507-11,931452,478
Three months ended April 30, 2025Cost of sales145,533111,63773,702-9,776321,096
Three months ended April 30, 2025Gross Margin57,40252,33023,805-2,155131,382
Three months ended April 30, 2025Gross Margin %28.3%31.9%24.4%29.0%
Three months ended April 30, 2025Selling, general and administrative (1)32,25921,67310,8505,55170,333
Three months ended April 30, 2025Restructuring charges89640936
Three months ended April 30, 2025Depreciation and amortization10,3617,4375,437-4,04319,192
Three months ended April 30, 2025Operating income (loss)13,88623,2207,518-3,70340,921
Three months ended April 30, 2025Depreciation and amortization10,3617,4375,437-4,04319,192
Three months ended April 30, 2025EBITDA24,24730,65712,955-7,74660,113
Three months ended April 30, 2025Expense related to plant relocation (Cost of sales)976976
Three months ended April 30, 2025Expense related to plant relocation (SG&A)246246
Three months ended April 30, 2025Transaction, advisory fees, reorganization costs, and product recall expenses59319252864
Three months ended April 30, 2025Restructuring charges89640936
Three months ended April 30, 2025Adjusted EBITDA26,95830,67612,955-7,45463,135
Three months ended April 30, 2025Adjusted EBITDA Margin %13.3%18.7%13.3%14.0%
Six months ended April 30, 2026Net sales392,131304,749193,055-18,479871,456
Six months ended April 30, 2026Cost of sales313,116210,590150,441-19,010655,137
Six months ended April 30, 2026Gross Margin79,01594,15942,614531216,319
Six months ended April 30, 2026Gross Margin %20.2%30.9%22.1%24.8%
Six months ended April 30, 2026Selling, general and administrative (1)69,94342,80527,0396,071145,858
Six months ended April 30, 2026Depreciation and amortization23,24014,68010,62635348,899
Six months ended April 30, 2026Operating (loss) income-14,16836,6744,949-5,89321,562
Six months ended April 30, 2026Depreciation and amortization23,24014,68010,62635348,899
Six months ended April 30, 2026EBITDA9,07251,35415,575-5,54070,461
Six months ended April 30, 2026Expense related to plant relocation (Cost of sales)528528
Six months ended April 30, 2026Credit related to plant relocation (SG&A)-8-8
Six months ended April 30, 2026Reorganization costs1461423570
Six months ended April 30, 2026Adjusted EBITDA9,73851,35415,576-5,11771,551
Six months ended April 30, 2026Adjusted EBITDA Margin %2.5%16.9%8.1%8.2%
Six months ended April 30, 2025Net sales387,675303,597182,545-21,295852,522

Income Statement

NA Fenestration (in thousands)

Three months ended April 30, 2025 – NA FenestrationHardware Solutions(1)NA FenestrationHardware Solutions(1)Three months ended April 30, 2025 – EU FenestrationExtruded Solutions(2)EU FenestrationExtruded Solutions(2)Three months ended April 30, 2025 – NA Cabinet ComponentsCustom Solutions(3)NA Cabinet ComponentsCustom Solutions(3)Three months ended April 30, 2025 – TymanTymanThree months ended April 30, 2025 – Unallocated Corp & OtherUnallocated Corp & OtherThree months ended April 30, 2025 – TotalTotal
Net sales151,02661,25751,237190,107-1,149452,478
Cost of sales113,76039,00142,405126,743-813321,096
Gross Margin37,26622,2568,83263,364-336131,382
Gross Margin %24.7%36.3%17.2%33.3%29.0%
Selling, general and administrative15,9389,0385,72537,2712,36170,333
Restructuring charges936936
Depreciation and amortization4,6672,6593,0158,7757619,192
Operating income (loss)16,66110,5599216,382-2,77340,921
Depreciation and amortization4,6672,6593,0158,7757619,192
EBITDA21,32813,2183,10725,157-2,69760,113
Expense related to plant relocation (Cost of sales)976976
Expense related to plant relocation (SG&A)246246
Transaction, advisory fees, and reorganization costs675189864
Restructuring charges related to severance and disposal of software936936
Adjusted EBITDA22,55013,2183,10726,768-2,50863,135
Adjusted EBITDA Margin %14.9%21.6%6.1%14.1%14.0%
Three months ended April 30, 2025Net sales202,935163,96797,507-11,931452,478
Three months ended April 30, 2025Cost of sales145,533111,63773,702-9,776321,096
Three months ended April 30, 2025Gross Margin57,40252,33023,805-2,155131,382
Three months ended April 30, 2025Gross Margin %28.3%31.9%24.4%29.0%
Three months ended April 30, 2025Selling, general and administrative32,25921,67310,8505,55170,333
Three months ended April 30, 2025Restructuring charges89640936
Three months ended April 30, 2025Depreciation and amortization10,3617,4375,437-4,04319,192
Three months ended April 30, 2025Operating (loss) income13,88623,2207,518-3,70340,921
Three months ended April 30, 2025Depreciation and amortization10,3617,4375,437-4,04319,192
Three months ended April 30, 2025EBITDA24,24730,65712,955-7,74660,113
Three months ended April 30, 2025Expense related to plant relocation (Cost of sales)976976
Three months ended April 30, 2025Expense related to plant relocation (SG&A)246246
Three months ended April 30, 2025Transaction, advisory fees, and reorganization costs59319252864
Three months ended April 30, 2025Restructuring charges related to severance and disposal of software89640936
Three months ended April 30, 2025Adjusted EBITDA26,95830,67612,955-7,45463,135

Balance Sheet (in thousands)

April 30, 2026October 31, 2025
Current assets:Cash and cash equivalents63,67176,018
Current assets:Restricted Cash2,3132,100
Current assets:Accounts receivable, net211,088205,384
Current assets:Inventories278,047254,122
Current assets:Income taxes receivable6,121
Current assets:Prepaid assets39,54232,387
Current assets:Other current assets3,6513,764
Current assets:Total current assets604,433573,775
Current assets:Property, plant and equipment, net399,190411,591
Current assets:Operating lease right-of-use assets176,809154,866
Current assets:Deferred tax assets2502,706
Current assets:Goodwill274,750271,346
Current assets:Intangible assets, net533,395549,137
Current assets:Other assets4,3484,812
Current assets:Total assets1,993,1751,968,233
Current liabilities:Accounts payable127,709131,307
Current liabilities:Accrued liabilities85,66695,155

Cash Flow (in thousands)

Six Months Ended April 30, – 2026Six Months Ended April 30, – 2025
Operating activities:Net (loss) income-7215,630
Adjustments to reconcile net loss to cash used for operating activities:Depreciation and amortization48,89943,932
Adjustments to reconcile net loss to cash used for operating activities:Stock-based compensation2,4021,825
Adjustments to reconcile net loss to cash used for operating activities:Deferred income tax9181,250
Adjustments to reconcile net loss to cash used for operating activities:Other, net3,8007,243
Changes in assets and liabilities:(Increase) decrease in accounts receivable-4,4795,322
Changes in assets and liabilities:Increase in inventory-21,719-1,333
Changes in assets and liabilities:Increase in other current assets-6,200-7,828
Changes in assets and liabilities:Decrease in accounts payable-2,459-14,771
Changes in assets and liabilities:Decrease in accrued liabilities-10,411-14,048
Changes in assets and liabilities:Change in income taxes-12,005-5,471
Changes in assets and liabilities:Other, net689-5,764
Changes in assets and liabilities:Cash (used for) provided by operating activities-1,28615,987
Investing activities:Capital expenditures-22,322-26,544
Investing activities:Proceeds from disposition of capital assets29376
Investing activities:Cash used for investing activities-22,293-26,168
Financing activities:Borrowings under credit facilities119,000125,000
Financing activities:Repayments of credit facility borrowings-99,500-117,500
Financing activities:Repayments of other long-term debt-1,762-1,888
Financing activities:Common stock dividends paid-7,277-7,552
Financing activities:Purchase of treasury stock-27,194
Financing activities:Other, net-696-1,186
Financing activities:Cash provided by (used for) financing activities9,765-30,320
Financing activities:Effect of exchange rate changes on cash and cash equivalents1,6802,303
Financing activities:Decrease in cash, cash equivalents and restricted cash-12,134-38,198
Financing activities:Cash, cash equivalents and restricted cash at beginning of period78,118102,995
Financing activities:Cash, cash equivalents and restricted cash at end of period65,98464,797
Financing activities:QUANEX BUILDING PRODUCTS CORPORATION FREE CASH FLOW AND NET DEBT RECONCILIATION (In thousands) (Unaudited)QUANEX BUILDING PRODUCTS CORPORATION FREE CASH FLOW AND NET DEBT RECONCILIATION (In thousands) (Unaudited)QUANEX BUILDING PRODUCTS CORPORATION FREE CASH FLOW AND NET DEBT RECONCILIATION (In thousands) (Unaudited)

Cash Flow

Three Months Ended April 30, (in thousands)

Three Months Ended April 30, – 2026Three Months Ended April 30, – 2025Six Months Ended April 30, – 2026Six Months Ended April 30, – 2025
Cash (used for) provided by operating activities18,92228,497-1,28615,987
Capital expenditures-11,028-14,920-22,322-26,544
Free Cash Flow7,89413,577-23,608-10,557
Full release

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” “anticipate,” “intend,” “plan,” “project,” “seek,” “would,” “may,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, expectations regarding the recovery of price versus cost imbalances, anticipated debt repayment and share repurchase activity, expected operational efficiencies and synergies and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from those expressed or implied in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

(1) Includes $48.6 million and $57.4 million in real estate lease liabilities considered finance leases under U.S. GAAP as of April 30, 2026 and 2025, respectively.

(2) Excludes outstanding letters of credit.

(1) Expense related to plant closure/relocation.

(2) Transaction, advisory fees, reorganization costs and product recall expenses.

(3) Restructuring (credit) charges related to severance.

(1) Expense related to plant closure/relocation.... (truncated) inventory.

(3) Transaction, advisory fees, reorganization costs and product recall expenses.

(4) Restructuring charges related to severance and disposal of software.

(5) Amortization expense related to intangible assets.

(6) Foreign currency transaction (gains) losses.

(7) Tax impact of net income reconciling items.

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

(1) Includes stock-based compensation expense for the three and six months ended April 30, 2026, respectively of $1.5 million and $4.6 million and $0.6 million and $1.8 million for the comparable prior year periods.

This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated June 5, 2025 for the three and six months ended April 30, 2025, to the current presentation.

(1) The Hardware Solutions segment contains a portion of the previously reported NA Fenestration segment.

(2) The Extruded Solutions segment contains a portion of the previously reported NA Fenestration and the EU Fenestration segments.

(3) The Custom Solutions segment contains a portion of the previously reported NA Fenestration and the NA Cabinet Components segments.

(1) Reflects an increase of $4.4 million and $6.7 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2026, respectively.

(2) Reflects an increase of $5.9 million and $8.6 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2026, respectively.

(3) Reflects an increase of $0.5 million and $0.3 million in revenue associated with foreign currency exchange rate impacts for the three and six months ended April 30, 2026, respectively.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Quanex Building Products earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.